Vensica Medical is a medical device company that is designing and developing and Ultrasound catheter for the treatment of bladder cancer.
Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).
Using Vensica’s device, the drug will be instilled in a quick, pain-free procedure subsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).
Using Vensica’s device, the drug will be instilled in a quick, pain-free procedure subsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
Location: Israel, Center District, Netanya
Employees: 1-10
Total raised: $48M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | Israel Bio... | ibf.fund |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 04.11.2024 | - | $11M | - |
| 09.02.2022 | - | $19M | - |
| 02.11.2021 | - | $16M | - |
| 02.10.2017 | - | $2M | - |
Mentions in press and media 12
| Date | Title | Description |
| 04.11.2024 | Vensica Medical: A New Dawn in Urology Therapeutics | Vensica Medical is making waves in the world of urology. The New York City-based company recently secured $11 million in funding. This financial boost is a lifeline for innovation. It’s a step toward transforming the treatment of overactive... |
| 04.11.2024 | Vensica Medical: Urology Therapeutics Company Raises $11 Million | Vensica Medical – a pioneering urology therapeutics company, announced the closing of an $11 million funding round. This funding was led by Israel Biotech Fund (IBF), along with key strategic partners Merz (a global player in neurotoxins) a... |
| 28.10.2024 | Vensica Medical Raises $11M in Funding | (from l-r) Avner Geva, Vensica Therapeutics CEO & Co Founder; Avi Eftel, Vensica Therapeutics CTO & Co Founder Vensica Medical, NYC-based urology therapeutics company, raised $11M in funding. The round was led by Israel Biotech Fund... |
| 07.02.2022 | Vensica Closes $19 Million Round with Investment from Strategic Partner Merz | TEL AVIV, Israel, Feb. 7, 2022 /PRNewswire/ -- Vensica Therapeutics ("Vensica"), a clinical stage biopharmaceutical company, has closed a $19 million investment round. Vensica executed a strategic collaboration agreement with Merz... |
| 07.02.2022 | Vensica Raises $19M in Funding | Vensica CEO Avner Geva (at left) and VP R&D Avi Eftel. Vensica, a Tel Aviv, Israel-based clinical stage biopharmaceutical company, raised $19M in funding. Vensica executed a strategic collaboration agreement with Merz Therapeutics in 20... |
| 07.02.2022 | Vensica Medical Ltd. announced that it has received $19 million in funding from Israel Biotech Fund, Laborie Medical Technologies, Inc., The Trendlines Group Ltd., Agriline Ltd., Merz GmbH & Co. K... | On February 7, 2022, Vensica Medical Ltd. closed the transaction. The company amended the terms of the transaction and now raised up to $19 million in the transaction. The company received up to $3 million in its second tranche from new inv... |
| 02.11.2021 | Israeli drug developer, Vensica Therapeutics, raises $16m in an investment round led by IBF | - |
| 01.11.2021 | Vensica Therapeutics Closes $16 Million Investment Round | Vensica Therapeutics, a clinical stage biopharmaceutical company, announced that it has closed an investment round of $16 million. The investment round was led by Israel Biotech Fund (IBF), a venture fund investing in Israeli and Israeli-re... |
| 01.11.2021 | Vensica Therapeutics Raises $16M in Funding | The Vensica Therapeutics device (courtesy Vensica Therapeutics) (PRNewsfoto/Vensica Therapeutics) Vensica Therapeutics, a Tel Aviv, Israel-based clinical stage biopharmaceutical company, closed a $16m funding round. The round was led by Isr... |
| 01.11.2021 | Vensica Therapeutics closes $16 million investment round | Vensica Therapeutic's innovative ultrasound-assisted delivery catheter for needle-free use in urological procedures. Portfolio company, Vensica Therapeutics, a clinical stage biopharmaceutical company, announced that it has closed an invest... |
Show more